drugset / Trial / NCT00907114
Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of topic ketorolac in treatment for center point thickness secondary to panphotocoagulation in proliferative diabetic retinopathy.
Timeline
- Start
- 2009-06
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac Tromethamine | Small molecule | 0.25 mg | Topical |